Two newly identified SNPs in the apo AI-CIII intergenic region are strongly associated with familial combined hyperlipidaemia

European Journal of Clinical Investigation

Volumn 31, Issue 10, 2001, Pages 852-859

  Groenendijk, M ^a   Cantor, R M ^b   Funke, H ^c   Dallinga Thie, G M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Apolipoprotein CIII; Familial combined hyperlipidaemia; Lipids; Lipoproteins

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN C3; CHOLESTEROL; SPACER DNA; TRIACYLGLYCEROL;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FAMILIAL HYPERLIPEMIA; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HAPLOTYPE; HUMAN; PRIORITY JOURNAL; RELATIVE; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SPOUSE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ALLELES; APOLIPOPROTEIN A-I; APOLIPOPROTEIN C-III; APOLIPOPROTEINS C; BASE SEQUENCE; DNA, INTERGENIC; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT, HERITABLE;

EID: 0035740398     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2001.00888.x     Document Type: Article

References (36)

1. Hyperlipidemia in coronary heart disease II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia
2. Impaired chylomicron remnant clearance in familial combined hyperlipidemia
3. Genetics and molecular biology of familial combined hyperlipidemia
4. Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype
5. Inherited susceptibility determines the distribution of dense low-density lipoprotein subfraction profiles in familial combined hyperlipidemia
6. Pedigree and sib-pair linkage analysis suggest the apolipoprotein B gene is not the major gene influencing plasma apolipoprotein B levels
7. A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11
8. Genomewide scan for familial combined hyperlipidemia genes in Finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels
9. Lipoprotein lipase gene mutation G460C in familial combined hyperlipidemia
10. Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia
11. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: Effects on LDL-cholesterol and apolipoproteins B and C-III
12. An apolipoprotein C-III haplotype protective against hypertriglyceridemia is specified by promotor and 30 untranslated region polymorphisms
13. Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease
14. Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia
15. Hypertriglyceridemia and the apolipoprotein CIII gene locus: Lack of association with the variant insulin response element in Italian school children
16. Deoxyribonucleic acid polymorphism in the apolipoprotein AI-CIII gene cluster. Association with hypertriglyceridemia
17. Haplotypes identified by DNA restriction-fragment length polymorphisms in the A-I CIII-AIV gene region and hypertriglyceridemia
18. Genetic markers in the apo AI-CIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis
19. DNA polymorphisms of apolipoprotein A-I/C-III and insulin genes in familial hypertriglyceridemia and coronary heart disease
20. ApoCIII gene variants modulate postprandial response to both glucose and fat tolerance tests
21. Evidence against linkage of familial combined hyperlipidemia to the apolipoprotein AI-CIII-AIV gene complex
22. Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipidemia in French Canadian subjects
23. DNA restriction fragment length polymorphisms as markers of familial coronary heart disease
24. Lack of association between genetic variations of apo A-I-C-III-A-IV gene cluster and myocardial infarction in a sample of European male
25. Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes
26. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia
27. A simple salting out procedure for extracting DNA from human nucleated cells
28. Sensitivity of Fisher's exact test to minor perturbations in 2 × 2 contingency table
29. The TDT and other family-based tests for linkage disequilibrium and association
30. Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia
31. Familial combined hyperlipidemia linked to the apolipoprotein AI-CIII-AIV gene cluster on chromosome 11q23-q24
32. Association between genetic variation at the Apo AI-CIII-AIV gene cluster and familial combined hyperlipidemia
33. Haplotypes of the ApoA-I/C-III/A-IV gene cluster and familial combined hyperlipidemia
34. The 3′-flanking region shared by the human apolipoprotein AI and CIII gene regulates gene expression in cooperation with 5′-flanking elements
35. Distal apolipoprotein C-III regulatory elements F to J act as a general modular enhancer for proximal promoters that contain hormone response elements - Synergism between hepatic nuclear factor-4 molecules bound to the proximal promoter and distal enhancer sites
36. Binding specificity and modulation of the human apoCIII promoter activity by heterodimers of ligand-dependent nuclear receptors